181
Participants
Start Date
October 31, 2013
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Sham control
The sham vial did not contain active drug (empty sterile vial). The sham injection was an imitation of an intravitreal injection using an injection syringe without a needle touching the eye.
Ranibizumab
Ranibizumab 0.5mg/0.5mL was administered intravitreally to the participant.
Novartis Investigative Site, Riga
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Sydney
Novartis Investigative Site, Westmead
Novartis Investigative Site, Leuven
Novartis Investigative Site, Bern
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Binningen
Novartis Investigative Site, Adelaide
Novartis Investigative Site, Hobart
Novartis Investigative Site, South Launceston
Novartis Investigative Site, Zurich
Novartis Investigative Site, Torino
Novartis Investigative Site, Genova
Novartis Investigative Site, Milan
Novartis Investigative Site, Málaga
Novartis Investigative Site, Saint-Jean
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Kocaeli
Novartis Investigative Site, Valladolid
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Florence
Novartis Investigative Site, Pisa
Novartis Investigative Site, Lyon
Novartis Investigative Site, Paris
Novartis Investigative Site, Freiburg I. Br
Novartis Investigative Site, Trenčín
Novartis Investigative Site, Regensburg
Novartis Investigative Site, Banská Bystrica
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Singapore
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Kfar Saba
Novartis Investigative Site, Tel Aviv
Novartis Investigative Site, Rehovot
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, Halifax
Novartis Investigative Site, Pilsen
Novartis Investigative Site, Prague
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Szeged
Novartis Investigative Site, Roma
Novartis Investigative Site, Tilburg
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Busan
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Sant Cugat del Vallès
Novartis Investigative Site, Ankara
Novartis Investigative Site, Frimley
Novartis Investigative Site, London
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Bristol
Novartis Investigative Site, Manchester
Novartis Investigative Site, Southampton
Novartis Investigative Site, Sunderland
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY